Comparing the outcomes of ceftaroline plus vancomycin or daptomycin combination therapy versus vancomycin or daptomycin monotherapy in adults with methicillin-resistant staphylococcus aureus bacteremia—a meta-analysis

HIGHLIGHTS

  • who: Chienhsiu Huang and collaborators from the DepartmentChiayi, Taiwan have published the article: Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant Staphylococcus aureus Bacteremia—A Meta-Analysis, in the Journal: Antibiotics 2022, 11, x FOR PEER REVIEW 2.1 Characteristics of the Included Trials of 15/08/2022
  • what: Regarding the duration of bacteremia, four studies reported no statistically significant difference in the duration of bacteremia between the patients treated with monotherapy and those treated with ceftaroline combination therapy . The studies were . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?